217 related articles for article (PubMed ID: 23149914)
1. Common single-nucleotide polymorphisms in the estrogen receptor β promoter are associated with colorectal cancer survival in postmenopausal women.
Passarelli MN; Phipps AI; Potter JD; Makar KW; Coghill AE; Wernli KJ; White E; Chan AT; Hutter CM; Peters U; Newcomb PA
Cancer Res; 2013 Jan; 73(2):767-75. PubMed ID: 23149914
[TBL] [Abstract][Full Text] [Related]
2. Association of genetic polymorphisms in ESR2, HSD17B1, ABCB1, and SHBG genes with colorectal cancer risk.
Sainz J; Rudolph A; Hein R; Hoffmeister M; Buch S; von Schönfels W; Hampe J; Schafmayer C; Völzke H; Frank B; Brenner H; Försti A; Hemminki K; Chang-Claude J
Endocr Relat Cancer; 2011 Apr; 18(2):265-76. PubMed ID: 21317201
[TBL] [Abstract][Full Text] [Related]
3. Estrogen and progesterone-related gene variants and colorectal cancer risk in women.
Lin JH; Manson JE; Kraft P; Cochrane BB; Gunter MJ; Chlebowski RT; Zhang SM
BMC Med Genet; 2011 May; 12():78. PubMed ID: 21627810
[TBL] [Abstract][Full Text] [Related]
4. Common colorectal cancer risk variants in SMAD7 are associated with survival among prediagnostic nonsteroidal anti-inflammatory drug users: a population-based study of postmenopausal women.
Passarelli MN; Coghill AE; Hutter CM; Zheng Y; Makar KW; Potter JD; Newcomb PA
Genes Chromosomes Cancer; 2011 Nov; 50(11):875-86. PubMed ID: 21910156
[TBL] [Abstract][Full Text] [Related]
5. Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women.
Rivadeneira F; van Meurs JB; Kant J; Zillikens MC; Stolk L; Beck TJ; Arp P; Schuit SC; Hofman A; Houwing-Duistermaat JJ; van Duijn CM; van Leeuwen JP; Pols HA; Uitterlinden AG
J Bone Miner Res; 2006 Sep; 21(9):1443-56. PubMed ID: 16939403
[TBL] [Abstract][Full Text] [Related]
6. Association of estrogen receptor beta variants and serum levels of estradiol with risk of colorectal cancer: a case control study.
Wu H; Xu L; Chen J; Hu J; Yu S; Hu G; Huang L; Chen X; Yuan X; Li G
BMC Cancer; 2012 Jul; 12():276. PubMed ID: 22759347
[TBL] [Abstract][Full Text] [Related]
7. Profiling estrogen, progesterone, and androgen receptors in colorectal cancer in relation to gender, menopausal status, clinical stage, and tumour sidedness.
Refaat B; Aslam A; Idris S; Almalki AH; Alkhaldi MY; Asiri HA; Almaimani RA; Mujalli A; Minshawi F; Alamri SA; AlHussain MI; Baltow BA; Alqasmi MH; Basfar GT; Alosaimi OM; Muhayya IA
Front Endocrinol (Lausanne); 2023; 14():1187259. PubMed ID: 37206439
[TBL] [Abstract][Full Text] [Related]
8. Repeat polymorphisms in ESR2 and AR and colorectal cancer risk and prognosis: results from a German population-based case-control study.
Rudolph A; Shi H; Försti A; Hoffmeister M; Sainz J; Jansen L; Hemminki K; Brenner H; Chang-Claude J
BMC Cancer; 2014 Nov; 14():817. PubMed ID: 25376484
[TBL] [Abstract][Full Text] [Related]
9. No association between germline variation in catechol-O-methyltransferase and colorectal cancer survival in postmenopausal women.
Passarelli MN; Newcomb PA; Makar KW; Burnett-Hartman AN; Phipps AI; David SP; Hsu L; Harrison TA; Hutter CM; Duggan DJ; White E; Chan AT; Peters U
Menopause; 2014 Apr; 21(4):415-20. PubMed ID: 23880798
[TBL] [Abstract][Full Text] [Related]
10. Polymorphisms in the promoter region of ESR2 gene and breast cancer susceptibility.
Treeck O; Elemenler E; Kriener C; Horn F; Springwald A; Hartmann A; Ortmann O
J Steroid Biochem Mol Biol; 2009 Apr; 114(3-5):207-11. PubMed ID: 19429453
[TBL] [Abstract][Full Text] [Related]
11. ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer.
Leyland-Jones B; Gray KP; Abramovitz M; Bouzyk M; Young B; Long B; Kammler R; Dell'Orto P; Biasi MO; Thürlimann B; Harvey V; Neven P; Arnould L; Maibach R; Price KN; Coates AS; Goldhirsch A; Gelber RD; Pagani O; Viale G; Rae JM; Regan MM;
Breast Cancer Res Treat; 2015 Dec; 154(3):543-55. PubMed ID: 26590813
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor genotypes and haplotypes associated with breast cancer risk.
Gold B; Kalush F; Bergeron J; Scott K; Mitra N; Wilson K; Ellis N; Huang H; Chen M; Lippert R; Halldorsson BV; Woodworth B; White T; Clark AG; Parl FF; Broder S; Dean M; Offit K
Cancer Res; 2004 Dec; 64(24):8891-900. PubMed ID: 15604249
[TBL] [Abstract][Full Text] [Related]
13. Impact of estrogen receptor gene polymorphisms and mRNA levels on obesity and lipolysis--a cohort study.
Nilsson M; Dahlman I; Jiao H; Gustafsson JA; Arner P; Dahlman-Wright K
BMC Med Genet; 2007 Dec; 8():73. PubMed ID: 18053221
[TBL] [Abstract][Full Text] [Related]
14. Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study.
Banday MZ; Sameer AS
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988064
[No Abstract] [Full Text] [Related]
15. Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy.
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
Int J Cancer; 2010 Jun; 126(12):2935-46. PubMed ID: 19739075
[TBL] [Abstract][Full Text] [Related]
16. Association of estrogen receptor and progesterone receptor genetic polymorphisms with recurrent pregnancy loss: A systematic review and meta-analysis.
Huang X; Yin T; Song M; Pan J
Eur J Obstet Gynecol Reprod Biol; 2024 May; 296():65-75. PubMed ID: 38402782
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-10 -592C/A, but not -1082A/G promoter single nucleotide polymorphism, is associated with a decreased risk of colorectal cancer in an ethnic Kashmiri population: a case-control study.
Banday MZ; Sameer AS; Chowdri NA; Haq E
Eur J Cancer Prev; 2017 Nov; 26(6):476-490. PubMed ID: 28538040
[TBL] [Abstract][Full Text] [Related]
18. Polymorphisms in the promoter region of estrogen receptor β gene in endometrial cancer.
Lattrich C; Häring J; Schüler S; Skrzypczak M; Ortmann O; Treeck O
Arch Gynecol Obstet; 2014 Mar; 289(3):631-5. PubMed ID: 23974281
[TBL] [Abstract][Full Text] [Related]
19. Estrogen receptor genotype and risk of cognitive impairment in elders: findings from the Health ABC study.
Yaffe K; Lindquist K; Sen S; Cauley J; Ferrell R; Penninx B; Harris T; Li R; Cummings SR
Neurobiol Aging; 2009 Apr; 30(4):607-14. PubMed ID: 17889406
[TBL] [Abstract][Full Text] [Related]
20. Estrogen receptor-beta genetic variations and overall survival in patients with locally advanced gastric cancer.
Sunakawa Y; Cao S; Berger MD; Matsusaka S; Yang D; Zhang W; Ning Y; Parekh A; Stremitzer S; Mendez A; Okazaki S; Wakatsuki T; Azuma M; Shimada K; Watanabe M; Koizumi W; Wu AH; Lenz HJ
Pharmacogenomics J; 2017 Jan; 17(1):36-41. PubMed ID: 26503819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
